It was also unable to compare the prognostic performance of vascular-metabolic profiles to well-known pathological risk factors such as tumour regression score, circumferential resection margin, lymphovascular/perineural invasion, microsatellite instability, KRAS, NRAS, BRAF mutations. The gene discussed is NRAS; the disease is neoplasm.